Updated: Jan 17, 2008
Roy Meadow, MD, coined the term Munchausen syndrome by proxy in 1977 after observing 2 cases of mothers causing their children to be ill.
The cardinal feature of Munchausen syndrome by proxy is the production or feigning of physical or psychological symptoms in another person, usually a child or adult under the care of another. Secondary or external factors are not present. The person often lacks other mental or physical illnesses.
The caretaker simulates or induces symptoms of an illness and then takes the child or other person to seek medical attention, disavowing knowledge of the source of the problem. The deception may arise from anger or a desire for attention, which is satisfied by having a relationship with a practitioner.
Most symptoms are physical complaints, whereas feigning of mental symptoms occurs to a lesser extent. Physical presentations include vomiting, diarrhea, respiratory arrest, asthma, seizure, recurrent conjunctivitis, clumsiness, syncope, fever, infection, bleeding, failure to thrive, or electrolytic disturbance. For example, polymicrobial sepsis in a central line is extremely rare and should elicit consideration of the possibility of tampering. Another example is finding carbamazepine in the blood of a patient to whom the drug was not prescribed or finding a high level in a patient in whom it was discontinued.
Clinicians are trained to elicit the history of a sick child from his or her parents. A parent with Munchausen syndrome by proxy, usually the biologic mother, recounts serious but vague symptoms. This information may result in the performance of many laboratory tests and other procedures, including surgery. The child does not contradict the information because of fear. The outcome for the child could be serious injury or even death.
Although Munchausen syndrome by proxy is not formally listed as a diagnosis in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR),1 it can be found as factitious disorder not otherwise specified.
Many authorities consider Munchausen syndrome by proxy a lethal form of child abuse in which the action is voluntary (not impulsive) and potentially harmful to normal development.
Most cases of Munchausen syndrome by proxy are reported in the pediatric literature. Although the exact pathophysiology is unknown, a number of theories have been postulated.
Most people turn to the psychodynamic literature, which emphasizes a reaction to loss or a way to obtain attention and nurturing, a way to feel powerful, or a way of just acting out as possible explanations for this syndrome.
Some investigators offer unspecified brain dysfunction as an explanation. In this theory, the mother may have experienced abuse as a child, or she may be simply rejecting her childhood for some unknown reason.
Munchausen syndrome by proxy may be explained as a parent's pathologic relationship with a child. The mother may receive a psychological reward in the form of attention she receives from medical staff.
Frequency is unknown.2
Although the true prevalence is unknown, Munchausen syndrome by proxy is increasingly recognized and reported worldwide.
A wide variety of morbidity, ranging from infection of unknown origin to unexplained death, is noted. The mortality rate is approximately 6%.3
A racial or ethnic predilection for this condition has not been determined, but most mothers are Caucasian.
Approximately 98% of persons with Munchausen syndrome by proxy are women.4
Whether a certain age group is more likely to have the condition remains unknown.
Factitious disorder by proxy
The DSM-IV-TR includes the following research criteria for factitious disorder by proxy:
Factitious disorder not otherwise specified
The category of factitious disorder not otherwise specified includes disorders with contrived symptoms that do not meet the criteria for a factitious disorder, such as factitious disorder by proxy (ie, the intentional production or feigning of physical or psychological signs or symptoms in another person for the purpose of indirectly assuming the sick role).
Obtain a complete history and perform complete mental status, physical, and neurologic examinations to assist with the evaluation and to exclude other disease processes.
Research does not yet show a single cause for Munchausen syndrome by proxy.
Factitious Disorder
Malingering
Standard medical workup for Munchausen syndrome by proxy is unlikely to provide useful information, other than findings that exclude medical conditions that could account for psychiatric pathology in the parent.
Laboratory tests may include these:
Toxicologic tests and DNA typing might also be indicated.
Perform CT scanning or MRI if intracranial pathology is likely or if findings from neurologic examination are abnormal.
Indications for inpatient treatment include suicidal or homicidal ideations and grave disability (ie, patients who are dangerous to themselves or others or who cannot care for themselves).
Treatment of Munchausen syndrome by proxy involves treating the child (victim), the patient, and the family.
The literature provides little information regarding psychotherapy for Munchausen syndrome by proxy.
Treatment for the child
Treatment for the child comprises several areas, as follows:
Treatment for the patient with Munchausen syndrome by proxy
Treatment of the person with Munchausen syndrome by proxy involves thorough evaluation, individual therapy, and parenting classes, among other facets. Without treatment, the relapse rate is high. It is important not to overlook any medical and other psychiatric illnesses.
Hospitalization
Hospitalization of the patient and/or child may be necessary to ensure that both the patient and the child are in safe but separate environments. The patient's condition must be understood without becoming judgmental toward him or her, as this attitude can hamper therapy.
Family therapy
Family therapy starts with education regarding Munchausen syndrome by proxy and discussions about whether reunification of the patient and child might be possible.
If other children live in the patient's home, their health status should be evaluated, and appropriate treatment given. All members of the family should receive therapy; they include parents, siblings, and the affected child.
If the family is reunited, supervision is mandatory to ensure the child's safety.
Consultations with the following individuals may be indicated:
Restrict activity if patients are a danger to themselves or others or if they are gravely disabled.
No information is available regarding the use of medications in the treatment of Munchausen syndrome by proxy.
Patients may require further inpatient care if they are a danger to themselves or others or if they are gravely disabled.
The literature provides little information regarding psychotherapy for Munchausen syndrome by proxy.
No information is available.
If patients are charged with a crime or if they have been arrested, they may be incarcerated.
Deterrence and/or prevention may encompass these aspects:
Complications of Munchausen syndrome by proxy and its management include the following:
Patients with a good prognosis have the following characteristics:
Patients with a poor prognosis may exhibit the following signs:
Educating the patient, family, and medical staff about Munchausen syndrome by proxy is important.
For excellent patient education resources, visit eMedicine's Mental Health and Behavior Center. Also, see eMedicine's patient education article Munchausen Syndrome.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, Text Revision. Washington, DC: American Psychiatric Association; 200:517, 781-3.
Forsyth B. Munchausen syndrome by proxy. In: Melvin Lewis, ed. Child and Adolescent Psychiatry: A comprehensive textbook. 2nd ed. Baltimore, MD: Williams & Wilkins; 1996:1048-1054.
Sheridan MS. The deceit continues: an updated literature review of Munchausen Syndrome by Proxy. Child Abuse Negl. Apr 2003;27(4):431-51. [Medline].
The Nemours Foundation. Munchausen by proxy syndrome. 2007;5 Nov:Accessed Jan 4, 2008. Available at www.kidshealth.org/parent/general/sick/munchausen.html.
Adshead G, Bluglass K. Attachment representations in mothers with abnormal illness behaviour by proxy. Br J Psychiatry. Oct 2005;187:328-33. [Medline].
Ayoub CC, Schreier HA, Keller C. Munchausen by proxy: presentations in special education. Child Maltreat. May 2002;7(2):149-59. [Medline].
Bartsch C, Risse M, Schütz H, Weigand N, Weiler G. Munchausen syndrome by proxy (MSBP): an extreme form of child abuse with a special forensic challenge. Forensic Sci Int. Nov 26 2003;137(2-3):147-51. [Medline].
Baskin DE, Stein F, Coats DK, Paysse EA. Recurrent conjunctivitis as a presentation of munchausen syndrome by proxy. Ophthalmology. Aug 2003;110(8):1582-4. [Medline].
Bauer KA. Covert video surveillance of parents suspected of child abuse: the British experience and alternative approaches. Theor Med Bioeth. 2004;25(4):311-27. [Medline].
Bools C. Factitious illness by proxy. Munchausen syndrome by proxy. Br J Psychiatry. Sep 1996;169(3):268-75. [Medline].
Bools C, Neale B, Meadow R. Munchausen syndrome by proxy: a study of psychopathology. Child Abuse Negl. Sep 1994;18(9):773-88. [Medline].
Bornemann MA, Mahowald MW, Schenck CH. Parasomnias: clinical features and forensic implications. Chest. Aug 2006;130(2):605-10. [Medline].
Boros SJ, Ophoven JP, Andersen R, Brubaker LC. Munchausen syndrome by proxy: a profile for medical child abuse. Aust Fam Physician. May 1995;24(5):768-9, 772-3. [Medline].
Donald T, Jureidini J. Munchausen syndrome by proxy. Child abuse in the medical system. Arch Pediatr Adolesc Med. Jul 1996;150(7):753-8. [Medline].
Feldman MD, Brown RM. Munchausen by Proxy in an international context. Child Abuse Negl. May 2002;26(5):509-24. [Medline].
Folks DG. Munchausen's syndrome and other factitious disorders. Neurol Clin. May 1995;13(2):267-81. [Medline].
Forsyth BWC. Munchausen syndrome by proxy. In: Lewis M, ed. Child and Adolescent Psychiatry: A Comprehensive Textbook. 2nd ed. Baltimore, Md: Lippincott Williams & Wilkins; 1996:1048-54.
Lesaca TG. At mother's mercy: the nightmare of Munchausen syndrome by proxy. W V Med J. Nov-Dec 1995;91(7):318-9. [Medline].
Marcus A, Ammermann C, Klein M, Schmidt MH. Munchausen syndrome by proxy and factitious illness: symptomatology, parent-child interaction, and psychopathology of the parents. Eur Child Adolesc Psychiatry. Oct 1995;4(4):229-36. [Medline].
Maxmen JS, Ward NG. Factitious disorders. In: Essential Psychopathology and Its Treatment. 2nd ed. New York, NY: W.W. Norton & Company; 1995:304-9.
Meadow R. Munchausen syndrome by proxy. Arch Dis Child. Feb 1982;57(2):92-8. [Medline].
Moldavsky M, Stein D. Munchausen Syndrome by Proxy: two case reports and an update of the literature. Int J Psychiatry Med. 2003;33(4):411-23. [Medline].
Murray JB. Munchausen syndrome/Munchausen syndrome by proxy. J Psychol. May 1997;131(3):343-52. [Medline].
Pankratz L. Persistent problems with the Munchausen syndrome by proxy label. J Am Acad Psychiatry Law. 2006;34(1):90-5. [Medline].
Rand DC, Feldman MD. An explanatory model for Munchausen by proxy abuse. Int J Psychiatry Med. 2001;31(2):113-26. [Medline].
Repper J. Munchausen syndrome by proxy in health care workers. J Adv Nurs. Feb 1995;21(2):299-304. [Medline].
Rogers R. Diagnostic, expanatory, and detection models of Munchausen by proxy: extrapolations from malingering and deception. Child Abuse Negl. Feb 2004;28(2):225-38. [Medline].
Rosenberg DA. Munchausen Syndrome by Proxy: medical diagnostic criteria. Child Abuse Negl. Apr 2003;27(4):421-30. [Medline].
Sahin F, Kuruoglu A, Isik AF, Karacan E, Beyazova U. Munchausen syndrome by proxy: a case report. Turk J Pediatr. Oct-Dec 2002;44(4):334-8. [Medline].
Schreier HA, Libow JA. Munchausen syndrome by proxy: diagnosis and prevalence. Am J Orthopsychiatry. Apr 1993;63(2):318-21. [Medline].
Skau K, Mouridsen SE. Munchausen syndrome by proxy: a review. Acta Paediatr. Sep 1995;84(9):977-82. [Medline].
Thomas K. Munchausen syndrome by proxy: identification and diagnosis. J Pediatr Nurs. Jun 2003;18(3):174-80. [Medline].
Truman TL, Ayoub CC. Considering suffocatory abuse and Munchausen by proxy in the evaluation of children experiencing apparent life-threatening events and sudden infant death syndrome. Child Maltreat. May 2002;7(2):138-48. [Medline].
Ulinski T, Lhopital C, Cloppet H, Feït JP, Bourlon I, Morin D. Munchausen syndrome by proxy with massive proteinuria and gastrointestinal hemorrhage. Pediatr Nephrol. Jul 2004;19(7):798-800. [Medline].
Von Burg MM, Hibbard RA. Munchausen syndrome by proxy: a different kind of child abuse. Indiana Med. Sep-Oct 1995;88(5):378-82. [Medline].
Wenk RE. Molecular evidence of Munchausen syndrome by proxy. Arch Pathol Lab Med. Jan 2003;127(1):e36-7. [Medline].
Münchhausen syndrome by proxy, MSBP, Munchausen syndrome, Munchausen syndrome emergency, Munchausen syndrome by proxy emergency, Asher, Baron von Munchausen, Polle syndrome, Polle's syndrome, children of Munchausen, pediatric condition falsification, PCF, FD, factitious disease, factitious disorder, factitious disorder by proxy, factitious disorder not otherwise specified, factitious disorder NOS
malingering, psychiatric disorder, pseudosickness, pseudologues, mental disorder, child abuse emergency, physical child abuse, tampering, infection of unknown origin, unexplained death, feigned illness, faked illness, hospital hobo, pathomimicry disease forgery, doctor addicts, hospital addicts, hospital hoppers, professional patients, false patients, operation addicts, peregrinating problem patients, dissociative pseudologia fantastica, hypochondriasis, hypochondriacs, black-hole patients, fabricated symptoms, invented symptoms, personality disorders, somatoform disorder, sudden infant death syndrome
Guy E Brannon, MD, Associate Clinical Professor of Psychiatry, Louisiana State University Health Sciences Center; Director, Adult Psychiatry Unit, Chemical Dependency Unit, Clinical Research, Brentwood Behavior Health Company
Guy E Brannon, MD is a member of the following medical societies: American Medical Association, American Medical Writers Association, American Psychiatric Association, American Society of Addiction Medicine, Association of Clinical Research Professionals, Louisiana State Medical Society, and Southern Medical Association
Disclosure: AstraZeneca Honoraria Speaking and teaching; Takeda Honoraria Speaking and teaching; Wyeth Honoraria Speaking and teaching; Janssen Honoraria Speaking and teaching; Pfizer Honoraria Speaking and teaching
Kimberly S Carroll, MA, Clinical Research Coordinator, Brentwood Research Institute
Disclosure: Nothing to disclose.
Ronald C Albucher, MD, Chief Medical Officer, Westside Community Services; Consulting Staff, California Pacific Medical Center
Ronald C Albucher, MD is a member of the following medical societies: American Psychiatric Association
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.
Eduardo Dunayevich, MD, Adjunct Assistant Professor, Department of Psychiatry, University of Cincinnati; Clinical Research Physician, Neuroscience, Lilly Research Laboratories
Eduardo Dunayevich, MD is a member of the following medical societies: American Psychiatric Association
Disclosure: Nothing to disclose.
Harold H Harsch, MD, Program Director of Geropsychiatry, Department of Geriatrics/Gerontology, Associate Professor, Department of Psychiatry and Department of Medicine, Froedtert Hospital, Medical College of Wisconsin
Harold H Harsch, MD is a member of the following medical societies: American Psychiatric Association
Disclosure: lilly Honoraria Speaking and teaching; BMS Honoraria Speaking and teaching; Forest Labs Honoraria Speaking and teaching; AstraZeneca Honoraria Speaking and teaching; Pfizer Grant/research funds Other; Northstar Grant/research funds Other; Novartis Other; Pfizer Honoraria Speaking and teaching
Stephen Soreff, MD, President of Education Initiatives, Nottingham, NH; Faculty, Metropolitan College of Boston University, Boston, MA
Stephen Soreff, MD is a member of the following medical societies: American College of Mental Health Administration and American Psychosomatic Society
Disclosure: Nothing to disclose.
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)